In the study, NF-κB, PI3K/AKT, and MAPKs (p38, ERK1/2 and JNK) pathways were all investigated for the first time fully revealing the underlying molecular mechanism by which juglanin prevented lung cancer progression. This evidence concerns the gene MAPK8 and lung cancer.